Approval · Notice of Compliance 12481 · 2011
PREZISTA: Notice of Compliance 12481
Issued July 7, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12481
- Date
- July 7, 2011
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Human immunodeficiency virus (HIV) protease inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PREZISTA | 02369753 | Cancelled Post Market |
Medicinal ingredients
- DARUNAVIR 150 MG per TAB